GNAO1 as a Novel Predictive Biomarker for Late Relapse in Hepatocellular Carcinoma

Figure 5

Kaplan–Meier curves of OS of HCC patients based on GNAO1 expression (low versus high). (a–c) OS analysis of all HCC patients (n = 364), stage I-II (n = 253), and stage III-IV (n = 87) in the Kaplan–Meier plotter database; (d–e) OS analysis of all HCC patients (n = 79) and stage I-II (n = 64) based on the IHC results.

(a)

(b)

(c)

(d)

(e)